TY  - JOUR
AU  - Gudiol, C
AU  - Albasanz-Puig, A
AU  - Laporte-Amargos, J
AU  - Pallares, N
AU  - Mussetti, A
AU  - Ruiz-Camps, I
AU  - Puerta-Alcalde, P
AU  - Abdala, E
AU  - Oltolini, C
AU  - Akova, M
AU  - Montejo, M
AU  - Mikulska, M
AU  - Martin-Davila, P
AU  - Herrera, F
AU  - Gasch, O
AU  - Drgona, L
AU  - Paz Morales, H
AU  - Brunel, A-S
AU  - Garcia, E
AU  - Isler, B
AU  - Kern, W V
AU  - Morales, I
AU  - Maestro-de la Calle, G
AU  - Montero, M
AU  - Kanj, S S
AU  - Sipahi, O R
AU  - Calik, S
AU  - Marquez-Gomez, I
AU  - Marin, J I
AU  - Gomes, M Z R
AU  - Hemmatti, P
AU  - Araos, R
AU  - Peghin, M
AU  - Del Pozo, J L
AU  - Yañez, L
AU  - Tilley, R
AU  - Manzur, A
AU  - Novo, A
AU  - Carratalà, J
AU  - 
PY  - 2020
DO  - 10.1128/AAC.02494-19
UR  - http://hdl.handle.net/10668/15039
T2  - Antimicrobial agents and chemotherapy
AB  - We aimed to assess the rate and predictive factors of bloodstream infection (BSI) due to multidrug-resistant (MDR) Pseudomonas aeruginosa in neutropenic cancer patients. We performed a multicenter, retrospective cohort study including...
LA  - en
PB  - American Society for Microbiology
KW  - Pseudomonas aeruginosa
KW  - Bacteremia
KW  - Bloodstream infection
KW  - Cancer
KW  - Multidrug resistant
KW  - Neutropenia
KW  - Predictive model
KW  - Risk factors
KW  - Anti-bacterial agents
KW  - Bacteremia
KW  - Drug resistance, multiple, bacterial
KW  - Female
KW  - Humans
KW  - Male
KW  - Microbial sensitivity tests
KW  - Middle aged
KW  - Models, biological
KW  - Neoplasms
KW  - Neutropenia
KW  - Pseudomonas infections
KW  - Pseudomonas aeruginosa
KW  - ROC curve
KW  - Retrospective studies
KW  - Risk factors
KW  - Treatment outcome
TI  - Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
TY  - research article
VL  - 64
ER  -